Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-24
DOI
10.1038/s41598-017-14690-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune targets and neoantigens for cancer immunotherapy and precision medicine
- (2016) Rong-Fu Wang et al. CELL RESEARCH
- Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response
- (2016) M. I. E. van Poelgeest et al. CLINICAL CANCER RESEARCH
- Engaging Natural Killer T Cells as ‘Universal Helpers’ for Vaccination
- (2016) Mary Speir et al. DRUGS
- Vaccine adjuvants as potential cancer immunotherapeutics
- (2016) Burcu Temizoz et al. INTERNATIONAL IMMUNOLOGY
- Adjuvants: Classification,Modus Operandi, and Licensing
- (2016) Juliana de Souza Apostólico et al. Journal of Immunology Research
- Infection History Determines the Differentiation State of Human CD8+T Cells
- (2015) Michiel C. van Aalderen et al. JOURNAL OF VIROLOGY
- Virus-specific T cells as correlate of (cross-)protective immunity against influenza
- (2015) Arwen F. Altenburg et al. VACCINE
- NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
- (2015) Regan J. Anderson et al. Chemical Science
- Effector and Central Memory Poly-Functional CD4+ and CD8+ T Cells are Boosted upon ZOSTAVAX® Vaccination
- (2015) Janet J. Sei et al. Frontiers in Immunology
- The Role of Invariant Natural Killer T Cells in Dendritic Cell Licensing, Cross-Priming, and Memory CD8+ T Cell Generation
- (2015) Catherine Gottschalk et al. Frontiers in Immunology
- Cancer vaccine adjuvants – recent clinical progress and future perspectives
- (2014) Abid H. Banday et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- IL-10–producing NKT10 cells are a distinct regulatory invariant NKT cell subset
- (2014) Duygu Sag et al. JOURNAL OF CLINICAL INVESTIGATION
- A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
- (2014) Regan J Anderson et al. Nature Chemical Biology
- Advances in the study of HLA-restricted epitope vaccines
- (2013) Lingxiao Zhao et al. Human Vaccines & Immunotherapeutics
- Frequency of Epitope-Specific Naive CD4+ T Cells Correlates with Immunodominance in the Human Memory Repertoire
- (2012) W. W. Kwok et al. JOURNAL OF IMMUNOLOGY
- Activated iNKT Cells Promote Memory CD8+ T Cell Differentiation during Viral Infection
- (2012) Emma C. Reilly et al. PLoS One
- Application of tissue engineering to the immune system: development of artificial lymph nodes
- (2012) Tom Cupedo et al. Frontiers in Immunology
- Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation
- (2010) Kirsten M.L. Hertoghs et al. JOURNAL OF CLINICAL INVESTIGATION
- Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell–licensed DCs
- (2010) Verena Semmling et al. NATURE IMMUNOLOGY
- Human naive and memory CD4+T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells
- (2009) Rebekka Geiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
- (2009) R. S. Akondy et al. JOURNAL OF IMMUNOLOGY
- Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity
- (2009) C. Guillonneau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach
- (2008) Peng Wang et al. PLoS Computational Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started